İçeriğe geç
akaturk Akademik ölçüm

OpenAlex konusu

Dermatology and Skin Diseases

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 2.474 eser 117 yazar konusu

Çalışmalar

2.474 eser

  1. The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper 2026

    Background: Topical corticosteroids (TCS) remain the first-line treatment for atopic dermatitis (AD) and related inflammatory skin diseases, yet no standardized definition of response exists. This gap contributes to heterogeneity in clinical practice and complicates trial design. We therefore aimed to develop consensu…

  2. Predictors of Early and Complete Skin Clearance (PASI100) in Patients With Psoriasis Receiving Biologic Therapy: A Real‐World Cohort Study 2026

    Background Early achievement of complete skin clearance (PASI100) is a key therapeutic goal in the management of moderate‐to‐severe psoriasis. Identifying predictors of early response to biologic therapy may improve treatment selection and optimize patient outcomes. Methods This retrospective cohort study included adu…

  3. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study 2026

    Symptomatic dermographism (SD), the most common chronic inducible urticaria subtype, manifests as strip-shaped, pruritic wheals after skin friction. Conclusive data on its associated factors are limited, and direct comparisons between individuals with and without SD remain scarce. We aimed to identify factors associat…

  4. Besin Proteini ile İndüklenen Alerjik Proktokolitli Olgularımızın Klinik ve Demografik Özelliklerinin Belirlenmesi 2026

    Amaç: Çocukluk çağı hastalıklarının önemli bir bölümünü oluşturan besin alerjileri bağışıklık sisteminin besinlere karşı anormal yanıt vermesi sonucunda oluşan hastalıklar grubudur. Bu çalışma, Çocuk Alerji Polikliniği’nde Besin proteini ilişkili alerjik proktokolit tanısı ile izlenen olguların klinik ve demografik öz…

  5. Comment on “The relantionship of FricTest responses with an urticaria activity score, urticaria control test and quality of life scales in patients with symptomatic dermographism” - Reply 2026

    Özet henüz yok.

  6. Aesthetic interventions in patients with allergic skin diseases: Risk assessment and evidence-based preventive risk management 2026

    The use of aesthetic dermatologic procedures in patients with underlying allergic and inflammatory skin diseases is on the rise, but specific safety considerations are often overlooked. Individuals with hypersensitivity to injectables, chronic inducible urticaria, allergic contact dermatitis, atopic dermatitis, or her…

  7. Probiotics for skin aging and skin conditions in the elderly 2026

    Skin aging is increasingly recognized as a process associated with the microbiome, characterized by barrier dysfunction, chronic low-grade inflammation, and degradation of the extracellular matrix. Current evidence suggests that age-related changes in both skin and gut microbiota contribute to "inflammaging" and impai…

  8. Beyond sensitization: real-life thresholds for cat allergy in children 2026

    Background: Cat sensitization is common in patients with allergic diseases and may not always produce clinical symptoms. Objective: This study aimed to assess the correlation between skin prick test (SPT), cat-specific immunoglobulin E (cat sIgE), and symptoms in sensitized children, and to determine optimal threshold…

  9. Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015–2025) 2026

    Objective: In recent years, the therapeutic use of Janus kinase (JAK) inhibitors in dermatology, particularly in the management of atopic dermatitis (AD), has expanded markedly. This bibliometric study aimed to characterize research themes, evaluate the scientific productivity of authors and countries, and identify em…

  10. Successful treatment of dupilumab-induced rosacea with upadacitinib in a patient with atopic dermatitis 2026

    Özet henüz yok.

  11. Elevated Baseline Systemic Inflammation Indices Predict Poor Response and Higher Relapse Risk in Chronic Spontaneous Urticaria Patients on Omalizumab 2026

    Amaç: Kronik Spontan Ürtiker (KSÜ) hastalarında Omalizumab'a altı aylık klinik yanıtı ve tedavi kesimi sonrası uzun vadeli nüks riskini öngörmede bazal Sistemik İmmün-İnflamasyon İndeksi (SIRI) ve Agregat Sistemik İnflamasyon İndeksi'nin (AISI) prediktif performansını değerlendirmektir. Gereç ve Yöntemler: Bu tek merk…

  12. Successful treatment of dupilumab-induced rosacea with upadacitinib in a patient with atopic dermatitis. 2026

    Özet henüz yok.

Akademisyenler

117 akademisyen